Biblio
Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma. Blood Adv. 2020;4(5):858-867.
Follicular lymphoma: 2014 update on diagnosis and management. Am J Hematol. 2014;89(4):429-36.
.